Hepion Executive Chairman Vincent S. LoPriore reports purchase of 10 million shares worth $500,000
HEPA•Executive chairman reports affiliated stock purchases
Vincent S. LoPriore, executive chairman, reported purchases of Hepion Pharmaceuticals common stock through affiliated entities.
- Gravitas Capital LP acquired 8 million shares at USD 0.05, lifting its reported stake to 14.25 million shares.
- Invictus Capital Advisors Pension Plan bought 2 million shares at USD 0.05, taking its reported stake to 16.25 million shares.
- Separate warrant purchases totalled 10 million, exercisable at USD 0.06 through 2031.
